Quantum Numbers Corp. Welcomes Francis Bellido to Its Board of Directors
2020年12月23日 - 10:00PM
(TSXV:QNC) Quantum Numbers Corp. (the "Corporation" or
"QNC"), announces today that the Board of Directors has appointed
Mr. Francis Bellido to its board of directors, effective
immediately.
Mr. Bellido has spent his career overseeing and
leading the development of several organizations in the healthcare
industry. He brings strong financial management expertise, deep
operating and leadership experience, and a global business
perspective that he acquired over 30 years of international
business in Biosciences, Healthcare and Financial industries.
Notably, Mr. Bellido managed a CA$300 Million
life science investment Fund (SGF-Santé) that produced several
important and key players in the Medical Device industry. He has a
proven ability to approach technical and scientific issues with a
solid business perspective. Mr. Bellido holds a PhD in medical
microbiology from the University of Geneva and a MBA with a
concentration in Finance from the University of Quebec at
Montreal.
Pierre Paul Samson, QNC’s Chairman commented: “I
am very pleased to welcome Mr. Bellido to our Board of Directors.
His pedigree is outstanding, his business and technical background
are most relevant to QNC’s plans and his established network in
healthcare will help us position our product offering with the
right industry targets. There’s unanimity with our current board
members, this latest appointment will help QNC move to the next
level.”
In connection with Mr. Bellido appointment to
the board of directors, Quantum has granted to him incentive stock
options to purchase 750,000 common shares. The exercise price of
the options is 6.5 cents per share. The options vest immediately
and will expire in three years. The options were granted under
Quantum's stock option plan.
About Quantum Numbers Corp.
QNC’s mission is to address the growing demand
for affordable hardware security in connected devices. An
innovative developer of cryptographic solutions based on Quantum
Random Number Generation, QNC’s advantage is tied to a
distinctively micro-size technology that is very low on energy
consumption, easily integrated with other OEM components and
especially low cost to allow for inexpensive high volume
production.
The Corporation has successfully secured 4 USPTO
patents, 2 patents awarded in Europe and currently has 2 patents
pending in 11 additional countries. In addition to its IP strategy,
QNC has developed an operational prototype that can address
multiple applications related to security and embedded use, which
can cater to a wide-variety of industries.
For more information, please visit our website
at www.quantumnumberscorp.com
To receive QNC press releases by email, send a
message to: info@quantumnumberscorp.com and specify "QNC press
releases" on the subject line. To unsubscribe QNC press releases,
please send a message to: info@quantumnumberscorp.com.
Marc Rousseaumrousseau@lvrcapital.ca
Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accept responsibility for the adequacy or
accuracy of this release.
Quantum Emotion (TSXV:QNC)
過去 株価チャート
から 11 2024 まで 12 2024
Quantum Emotion (TSXV:QNC)
過去 株価チャート
から 12 2023 まで 12 2024